Data on the epidemiological situation of leptospirosis in humans in Belgium is presented in annual reports, see below under ‘Other publications’.

In animals, seroprevalence levels vary between 10% and 40% depending on the year and the animal species.

Sciensano is home to the National Reference Laboratory for animal leptospirosis in Belgium and also has expertise in the molecular diagnosis of acute human cases within 10 days of the onset of symptoms. Sciensano is also responsible for the epidemiological surveillance of the disease in humans in Belgium. 

QR code

QR code for this page URL